Akari Therapeutics, Plc (AKTX) Stock Price

14.385 ▼ -0.615 (-4.10%)
Open: 14.57 Vol: 0 Day's range: 14.385 - 14.57 Jun 10, 15:56 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AKTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 14.61▼ 14.85▼ 14.85▼ 15.15▼ 13.53▲
MA10 15.02▼ 15.33▼ 15.33▼ 15.73▼ 9.48▲
MA20 15.25▼ 14.98▼ 14.85▼ 11.77▲ 5.06▲
MA50 15.65▼ 17.49▼ 16.82▼ 7.77▲ 2.45▲
MA100 18.37▼ 13.84▲ 10.90▲ 4.00▲ 2.17▲
MA200 17.22▼ 8.93▲ 6.59▲ 2.31▲ 3.93▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.054▼ 0.046▲ -0.067▼ -0.110▼ 1.395▲
RSI 37.956▼ 39.131▼ 42.739▼ 57.674▲ 71.137▲
STOCH 1.937▼ 20.667     20.667     21.799     64.693    
WILL %R -100.000▼ -100.000▼ -100.000▼ -57.123     -51.147    
CCI -119.062▼ -119.170▼ -122.900▼ -27.581     105.105▲
Latest Filters Detected On AKTX
▼ MACD $AKTX MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $AKTX Price Crossed Below MA(7) Set Alert
▼ GAP $AKTX Open Gap Down %2 Set Alert
CDL $AKTX Doji Candlestick Pattern Detected Set Alert
Akari Therapeutics, Plc News
Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari's Differentiated PH1 Payload Platform Following ASCO 2026
Thursday, June 04, 2026 06:39 AM
Discussion highlights growing importance on novel ADC payloads, and Akari’s ASCO data in KRAS-driven cancers and future potential. Access the Akari CEO Corner here. TAMPA, Fla.
Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO ...
Thursday, May 28, 2026 06:32 AM
CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers Watch the “What ...
Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor "What This Means" Segment Following ASCO ...
Thursday, May 28, 2026 06:29 AM
CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers TAMPA, Fla. and LONDON, (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc ...
AKTX historical stock data
date open high low close volume
10/06/26 14.57 14.57 14.385 14.385 30,700
09/06/26 15.91 15.91 14.48 15.00 16,348
08/06/26 15.08 15.9405 15.08 15.445 20,623
05/06/26 15.88 15.92 14.01 15.07 59,961
04/06/26 14.99 16.11 14.41 15.84 68,434
03/06/26 14.19 15.85 13.05 14.985 59,103
02/06/26 13.69 16.1999 13.4001 14.63 264,494
01/06/26 15.53 16.72 13.00 13.43 188,175
29/05/26 24.98 25.95 15.65 16.43 538,857
28/05/26 15.82 29.32 15.30 22.05 1,635,354
Quote Details
52wk Low:0.12
52wk High:29.32
Vol:0
Avg Vol(3m):13.3M
1Y Chng:+1,141.05%
1M Chng:+174.52%
Add to Watch List
More Information
Index US Composite
Market Cap. 24.32M